research use only

Giantin (Golgi Marker) Antibody [F5N17]

Cat.No.: F1556

    Application: Reactivity:

    Usage Information

    Dilution
    1:200-1:400
    Application
    IF
    Reactivity
    Human
    Source
    Mouse Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Positive Control HeLa cells; Hek293 cells
    Negative Control

    Datasheet & SDS

    Biological Description

    Specificity
    Giantin (Golgi Marker) Antibody [F5N17] detects endogenous levels of total Giantin protein.
    Clone
    F5N17
    Synonym(s)
    Golgin subfamily B member 1; 372 kDa Golgi complex-associated protein (GCP372); Giantin; Macrogolgin; GOLGB1
    Background
    Giantin (GOLGB1), also known as Giantin Golgi protein, is the largest mammalian golgin, a family of long coiled-coil proteins localized primarily to the cis/medial Golgi and serving as a key structural marker of Golgi integrity. Giantin consists of an extended rod-like coiled-coil cytoplasmic domain that forms a rigid scaffold, a C-terminal transmembrane anchor, and interaction motifs for proteins such as p115, GM130, GRASP65, Rab1, and SNAREs, enabling it to tether vesicles without reliance on specific key residues. It regulates Golgi architecture by inhibiting excessive fusion and interconnections between stacks and cisternae, ensuring the formation of discrete reaction compartments for sequential glycosylation; knockdown of Giantin leads to reduced fenestrae size and number, accelerated membrane protein diffusion, and increased cisternal connectivity, which slows intra-Golgi transport and impacts protein and lipid glycosylation. Biologically, Giantin tethers COPI vesicles to the cis-Golgi, facilitates ER-Golgi and intra-Golgi trafficking through complexes with coat proteins, and supports Golgi reassembly after mitosis or disruption by agents like brefeldin A or ethanol. It coordinates the secretory pathway for surface and lysosomal protein sorting, with its loss altering glycosylation patterns and cargo kinetics. Disease associations include Congenital Disorders of Glycosylation (CDG), connective tissue disorders, ciliopathies (from dynein-2 mislocalization), and impaired secretion due to trafficking defects.
    References
    • https://pubmed.ncbi.nlm.nih.gov/31544102/
    • https://pubmed.ncbi.nlm.nih.gov/7691276/

    Tech Support

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3

    If you have any other enquiries, please leave a message.